Observing quality of life in prostate cancer patients after biopsy and surgery
Observational Study of Patients Who Underwent Diagnostic Investigation (Prostate Biopsy) and/or Radical Prostatectomy Surgery.
This study looks at how the quality of life changes for men with prostate cancer after they have a biopsy or surgery, by collecting their experiences through questionnaires over many years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20000 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 1 site (Milan) |
| Trial ID | NCT06397755 on ClinicalTrials.gov |
What this trial studies
This observational study collects data on the quality of life and disease status of patients who have undergone prostate biopsy and/or radical prostatectomy. It involves both prospective and retrospective data collection, with patients followed for up to 50 years post-surgery. Participants will complete questionnaires before and after their surgical procedures to assess their experiences and outcomes. The data will be meticulously managed in accordance with strict guidelines to ensure patient privacy and adherence to good clinical practices.
Who should consider this trial
Good fit: Ideal candidates are adult patients over 18 years old with a suspicious prostate disease who are undergoing prostate biopsy and/or radical prostatectomy.
Not a fit: Patients under 18 years old or those with mental or physical disabilities that prevent them from participating in the study may not benefit.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term quality of life for prostate cancer patients, informing future treatment and care strategies.
How similar studies have performed: While observational studies on quality of life in cancer patients are common, the long-term follow-up aspect of this study may provide novel insights into patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a suspicious prostate disease who underwent prostate biopsy and/or radical prostatectomy; * Adult patients \> 18 years * Ability to read and sign the informed consent Exclusion Criteria: * Patients \< 18 years * mental or physical disability that may prevent the patient from satisfying the requirements of the protocol * Inability to read and sign the informed consent
Where this trial is running
Milan
- IRCCS Ospedale San Raffaele — Milan, Italy (Recruiting)
Study contacts
- Study coordinator: Andrea Salonia
- Email: salonia.andrea@hsr.it
- Phone: +39 0226435661
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.